AVIBACTAM
Sponsors
Hellenic Institute For The Study Of Sepsis, Assistance Publique Hopitaux De Paris, Centre Hospitalier Universitaire De Rennes, Pfizer
Conditions
HealthySevere infectionsantibiotic therapy in Sepsissepsis
Phase 1
Phase 3
A RANDOMIZED PROSPECTIVE CLINICAL TRIAL TO ASSESS PROCALCITONIN-GUIDANCE AND MOLECULAR-GUIDED DIAGNOSIS AS MAINSTAY FOR THERAPY OF SEVERE INFECTIONS (The MODIFY trial)
Active, not recruitingCTIS2022-502962-26-00
Start: 2023-09-14Target: 190Updated: 2025-11-03
BICCS - Beta-lactam Intermittent versus Continuous infusion and Combination antibiotic therapy in Sepsis
Not yet recruitingCTIS2024-516849-39-01
Target: 600Updated: 2025-12-02
BETARGET : Randomized trial of individualizing BETA-lactam taRGET combining therapeutic drug monitoring, minimal inhibitory concentration and model-based dose adjustment, in Intensive Care Units patients with gram negative bacilli infection
Not yet recruitingCTIS2025-522819-42-01
Target: 672Updated: 2026-08-06